Last week marked the FDA's deadline for compounders to stop making the obesity drug tirzepatide (Zepbound), leaving some ...

The way people are accessing GLP-1 medications Semaglutide and Tirzepatide is going to become very limited after the drugs ...

In a study in the journal Diabetes Technology & Therapeutics (DTT), investigators evaluated biomarkers for cardiovascular ...

Tirzepatide and semaglutide offer long-term health benefits but are not cost-effective, according to a study publi ...

Semaglutide and tirzepatide confer greater improvements in life expectancy than naltrexone/bupropion and ...

Tirzepatide has been shown to help people lose more weight compared to semaglutide at the dosage regimens currently available ...

Tirzepatide was associated with significant reductions in weight primarily due to fat mass loss while preserving lean mass in obesity.

Patients taking compounded weight loss drugs from online pharmacies share what it's like — and they couldn't go the ...

Weight loss drugs like tirzepatide and semaglutide are growing in popularity and offer significant health benefits, but they ...

Detailed price information for Lexaria Bioscience Corp (LEXX-Q) from The Globe and Mail including charting and trades.

Those in favor of the classification argue that excess fat accumulation/distribution is linked to sustained and serious ...

The Outsourcing Facilities Association is appealing a ruling that rejected their request for an injunction against the FDA’s declaration that the shortage of tirzepatide is over.